Akebia Therapeutics Inc (NASDAQ:AKBA)

9.79
Delayed Data
As of Jul 02
 +0.06 / +0.62%
Today’s Change
7.27
Today|||52-Week Range
28.33
-15.89%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close9.73
Today’s open9.69
Day’s range9.49 - 9.85
Volume233,968
Average volume (3 months)485,572
Market cap$296.7M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-513.74%
Earnings growth (this year)+74.88%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.01

Competitors

 Today’s
change
Today’s
% change
TKAITokai Pharmaceutical...-0.20-1.48%
SNTASynta Pharmaceutical...-0.02-0.91%
TBRATobira Therapeutics ...+0.27+1.61%
SVASinovac Biotech Ltd-0.03-0.57%
Data as of 3:59pm ET, 07/02/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$0.00
Annual profit (last year)-$37.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John P. Butler
CFO, Treasurer, SVP &
Head-Investor Relations
Jason A. Amello
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers